Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 June 2022 | Story Nonsindiso Qwabe | Photo Supplied
Enactus Qwaqwa Campus
Owning Their Future – Enactus students on the Qwaqwa Campus.

Empowered by the Enactus platform, a group of students on the Qwaqwa Campus are planting seeds of lifelong goodness in the Qwaqwa community.

Enactus is an international non-profit organisation that equips students to improve the world through entrepreneurial action by providing a platform for teams of outstanding students to create community development projects that put communities at the centre of improving their own livelihoods.

The group of seven students, namely Salima van Schalkwyk, Lehlohonolo Mokoena, Tubatse Moloi, Jennifer Links, Boikanyo Madisha, Bonagani Makwakwa, and Vuyo Mbamba, who are all pursuing undergraduate degrees in various disciplines, form part of Enactus.

Van Schalkwyk, the team leader and second-year Bachelor of Community Development student, said being part of Enactus has enabled them to make a tangible difference in the community around them.

“[As a team], we always assumed we knew what people go through on a daily basis, but we were in for a surprise. Despite the beautiful mountainous views of Qwaqwa, the people are in pain, one that is a cycle. When we look at all that we have discovered, all that we have heard and seen, we are moved to give the people of Qwaqwa a hand in being lifted to the surface.”

Leaving footprints of greatness for future generations

The team is currently competing in various competitions that seek to bring about social change. In 2021, the team was selected by MTN ICT as part of the top 12 nominees countrywide, receiving funding to develop an app that will assist students with mental health challenges. Apart from developing the app, they are also working on 7 Seeds, an agricultural enterprise that seeks to address the agricultural difficulties of a farm they identified in Qwaqwa.

Van Schalkwyk said they will be participating in the Enactus National Competition on 14 July 2022 and are gunning for the Enactus World Cup that will take place in Puerto Rico in October this year.

“Our vision as Enactus students is to create a better, more sustainable world for future generations. In the current economic situation our country is in, we believe that social entrepreneurship is the key to economic development and empowerment. Through Enactus, we hope to inspire many more students to submerge themselves in entrepreneurial activities. We live to leave footprints that lead to greatness for future generations,” she said.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept